Company
Attovia Therapeutics
Attovia™ is advancing a new generation of precision biologics for patients with high unmet need across immune-mediated diseases.
Also known as Attovia
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Attovia Therapeutics
- attovia.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
At the core of our strategy is the ATTOBODY™ platform, a powerful, modular protein design platform to create novel complex biologic medicines.
Loading relationship preview